ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,778.10
1.01%
S&P ASX All Technology
3,094.00
0.51%
Brent Oil
83.665
-0.28%
US Dollar vs AUD
1.5108
0.02%
Bitcoin
65,480.08
-1.51%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anixa Biosciences Inc (ANIX)

  7. Anixa Biosciences Inc (ANIX) News

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIX
DateTimeSourceHeadlineSymbolCompany
14/06/202423:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
13/06/202401:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
11/06/202400:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
08/06/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
08/06/202400:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
05/06/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
21/05/202421:30PR Newswire (US)Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
08/05/202422:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
08/05/202422:25PR Newswire (US)Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesNASDAQ:ANIXAnixa Biosciences Inc
06/05/202422:05PR Newswire (US)Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaNASDAQ:ANIXAnixa Biosciences Inc
30/04/202421:45PR Newswire (US)Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024NASDAQ:ANIXAnixa Biosciences Inc
18/04/202422:20PR Newswire (US)Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
14/03/202423:45PR Newswire (US)Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesNASDAQ:ANIXAnixa Biosciences Inc
11/03/202423:00PR Newswire (US)Anixa Biosciences Announces Presentation at 24th Annual World Vaccine CongressNASDAQ:ANIXAnixa Biosciences Inc
12/02/202423:30PR Newswire (US)Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
09/02/202408:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIXAnixa Biosciences Inc
30/01/202400:50PR Newswire (US)Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology ConferenceNASDAQ:ANIXAnixa Biosciences Inc
23/01/202423:55PR Newswire (US)Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
17/01/202411:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
17/01/202411:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
17/01/202411:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
17/01/202411:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
17/01/202411:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
17/01/202409:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIXAnixa Biosciences Inc
17/01/202408:43Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIXAnixa Biosciences Inc
17/01/202408:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIXAnixa Biosciences Inc
11/01/202401:00PR Newswire (US)Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024NASDAQ:ANIXAnixa Biosciences Inc
14/12/202323:15PR Newswire (US)Anixa Biosciences to Present at Biotech Showcase 2024NASDAQ:ANIXAnixa Biosciences Inc
07/12/202322:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
07/12/202310:00PR Newswire (US)Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ANIX

Your Recent History

USOTC
MDNXF
Medinex (PK)
LSE
T3GB
Ivz Ust 1-3 Gbh
TG
A3LDDN
Banque Federative du Cre...
BIT
ISAG
Exchange Traded
LSE
45HA
Inter-amer 40
LSE
40OS
Tesco 6%nt29
EU
ALCRB
Carbios
BIT
NSCIT5565402
Ministero Dell Economia ...
LSE
78BQ
Investec Bnk 24
EU
IRIS
Iris Financial
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved